An overview of the evolution of the atherosclerotic plaque: From fatty streak to plaque rupture and thrombosis

Zeitschrift fur Kardiologie

Volumn 89, Issue SUPPL. 7, 2000, Pages

  Rosenfeld, M E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Inflammation; Macrophages; Smooth muscle cells

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; HUMAN; MACROPHAGE; REVIEW; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FOAM CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPROTEINS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; NECROSIS; OXIDATION-REDUCTION; THROMBOSIS;

EID: 0033760302     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070045     Document Type: Review

References (49)

1. Atherosclerosis - An inflammatory disease
2. Initiation of atherosclerotic lesions in cholesterol-fed rabbits: I. Focal increases in arterial LDL concentration precede development of fatty streak lesions
3. Initiation of atherosclerotic lesion in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries
4. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix
5. Low density lipoprotein oxidation and its pathobiological significance
6. Mechanisms of oxidafive damage by myeloperoxidase in atherosclerosis and other inflammatory disorders
7. Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger-RNA colocalize with oxidation specific lipid-protein adducts
8. Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein
9. Fatty streak initiation in the WHHL and comparably hypercholesterolemic fat-fed rabbits
10. Upregulation of VCAM-1 and ICAM-1 at atherosclerosisprone sites on the endothelium in the ApoE-deficient mouse
11. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation
12. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
13. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that over-express human apolipoprotein B
14. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
15. Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages
16. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins
17. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
18. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
19. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
20. Epidemiology of Chlamydia pneumoniae in atherosclerosis
21. Cell-mediated immunity in atherosclerosis
22. Modified forms of low density lipoprotein and atherosclerosis
23. The 'best' of cholesterols, the 'worst' of cholesterols: A tale of two receptors
24. Receptors for oxidized low density lipoprotein
25. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein
26. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: Upregulated expression by TNF-alpha
27. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages
28. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36
29. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis
30. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
31. Inflammation, lipids, and free radicals: Lessons learned from the atherogenic process
32. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits
33. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF
34. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
35. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis
36. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis
37. Fibrous cap formation or destruction - The critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
38. The phenotypes of smooth muscle expressed in human atheroma
39. Macrophage influence on smooth muscle phenotype in atherogenesis
40. Apoptosis in the atherosclerotic plaque: Quantitative and qualitative aspects
41. Apoptosis is abundant in human atherosclerotic lesions especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
42. Endothelial dysfunction: From physiology to therapy
43. The role of nitric oxide in atherosclerosis
44. Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine
45. Role for NADPH/NADH oxidase in the modulation of vascular tone
46. Why do plaques rupture?
47. Atherosclerotic plaque caps are locally weakened when macrophages density is increased
48. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
49. Tissue factor in the pathogenesis of atherosclerosis